Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 09/20/2005


Featured Articles

- BenfoMax (Benfotiamine): Novel Support for Nerve, Retina and Kidney Function*

- NSK-SD™ nattokinase: An Interview with Ralph Holsworth, D.O.

- FDA Concludes that Chromium Picolinate is Safe; Approves First Qualified Health Claim

New Products

- Skin Health Program Launch

- Exciting New Multivitamin/mineral Formulations

- Vitamin E/Tocotrienol Products

Featured Abstracts

- Nattokinase maintains healthy fibrinolytic activity, supporting healthy blood flow…*

- Pycnogenol moderates appearance of age spots…*

-Pomegranate polyphenols support healthy angiogenesis balance for cellular support…*

-Olive polyphenol hydroxytyrosol provides promising cellular support potential…*

-Aloe polysaccharides stimulate fibroblast cells and support healthy immune activity in the epidermis…*

-Potassium aspartate supports healthy arterial blood flow…*

Quick Fact

-A note on VitaTrienols


FDA Concludes that Chromium Picolinate is Safe;
Approves First Qualified Health Claim

In August, the FDA recognized chromium picolinate as a safe nutritional supplement with credible evidence to support the first qualified health claim with regard to the role of chromium in healthy glucose metabolism.*

With regards to safety, the FDA made the following statement:

"FDA concludes at this time, under the preliminary requirements of 21 CFR 101.14(b)(3)(ii), that the use of chromium picolinate in dietary supplements as described in the [approved] qualified health claims discussed in section IV is safe and lawful under the applicable provisions Act."

Health claims are specific statements that describe a relationship between a food, food component, or dietary supplement ingredient and their ability to reduce the risk of a disease or health-related condition. "Qualified health claims" provide the FDA with the ability to add a disclaimer to a potential health claim if it feels the evidence does not meet the standard of "significant scientific agreement."

The qualified health claim for chromium picolinate approved by the FDA reads as follows:

"One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain."

The near future is likely to reveal more positive news about the role of chromium picolinate, as additional peer-reviewed studies are on track to be published in upcoming months.

The study cited by the FDA was conducted at the Pennington BioMedical Research Center, Louisiana State University System, where lead scientists suggest that 200-1,000 mcg of chromium as chromium picolinate plays an important role in healthy carbohydrate metabolism.*

For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure